Expression levels of TIM-3 in the B-cell lymphoma endothelium has been correlated with poor prognosis and TIM-3+ ECs suppressed the activation of CD4+ T cells inhibiting TH1 polarization in vitro and in vivo (273). This evidence concerns the gene HAVCR2 and B-cell non-Hodgkin lymphoma.